Cochlear Stock

Cochlear Gross Profit

The Gross Profit of Cochlear (COH.AX) as of Aug 22, 2026 is 1.73 B AUD. In the previous year, Gross Profit was 1.67 B AUD — a change of 3.25% (higher).

Gross Profit

1.73 BAUD

YoY

3.25%

Last updated:

Gross Profit of Cochlear is 2026 1.73 B AUD. Gross Profit of Cochlear was 2025 1.67 B AUD. It decreases by 3.25% higher compared to the previous year.

The Cochlear Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
1.01 B AUD
Jan 1, 2019
1.08 B AUD
Jan 1, 2020
984.40 M AUD
Jan 1, 2021
1.10 B AUD
Jan 1, 2022
1.25 B AUD
Jan 1, 2023
1.45 B AUD
Jan 1, 2024
1.67 B AUD
Jan 1, 2025
1.73 B AUD
The Cochlear Gross Profit history
YEARGross ProfitYoY
1.73 BAUD+3.25%
1.67 BAUD+15.57%
1.45 BAUD+15.81%
1.25 BAUD+13.79%
1.10 BAUD+11.63%
984.40 MAUD-9.04%
1.08 BAUD+7.65%
1.01 BAUD+11.44%
902.07 MAUD+10.92%
813.25 MAUD+23.14%
660.44 MAUD+18.32%
558.20 MAUD+2.22%
546.10 MAUD-5.94%
580.60 MAUD-1.24%
587.90 MAUD+9.13%
538.70 MAUD+7.52%
501.00 MAUD+15.15%
435.10 MAUD+9.29%
398.10 MAUD+23.90%
321.30 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Cochlear Revenue

Cochlear Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
2.24 B AUD
509.60 M AUD
356.80 M AUD
Jan 1, 2025
2.34 B AUD
522.90 M AUD
388.90 M AUD
Jan 1, 2026 (e)
2.33 B AUD
481.15 M AUD
309.97 M AUD
Jan 1, 2027 (e)
2.38 B AUD
491.40 M AUD
342.32 M AUD
Jan 1, 2028 (e)
2.53 B AUD
521.25 M AUD
379.36 M AUD
Jan 1, 2029 (e)
2.69 B AUD
555.72 M AUD
423.80 M AUD
Jan 1, 2030 (e)
3.08 B AUD
634.25 M AUD
487.96 M AUD
Jan 1, 2031 (e)
3.55 B AUD
0.00 AUD
685.12 M AUD

Cochlear Margins

Cochlear stock margins

The Cochlear margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cochlear. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cochlear.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
74.86 %
22.79 %
15.96 %
Jan 1, 2025
73.74 %
22.32 %
16.60 %
Jan 1, 2026 (e)
73.74 %
20.62 %
13.29 %
Jan 1, 2027 (e)
73.74 %
20.62 %
14.37 %
Jan 1, 2028 (e)
73.74 %
20.62 %
15.01 %
Jan 1, 2029 (e)
73.74 %
20.62 %
15.73 %
Jan 1, 2030 (e)
73.74 %
20.62 %
15.87 %
Jan 1, 2031 (e)
73.74 %
0.00 %
19.28 %

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Gross Profit of Cochlear is 1.73 B AUD in 2026.

Gross Profit of Cochlear changed from 1.67 B AUD to 1.73 B AUD, representing a 3.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Cochlear since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Cochlear historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Cochlear

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cochlear